GO:0061026 cardiac muscle tissue regeneration: Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061026 cardiac muscle tissue regeneration is the biological process of regrowth of cardiac muscle tissue to repair injured or damaged muscle fibers in the postnatal stage.
• The neonatal mouse heart transiently retains a robust regenerative capacity, but this ability is largely lost within the first week of life.
• Zebrafish retain lifelong cardiac regeneration and are a key model for discovering conserved mechanisms of heart repair.
• Telomere maintenance and telomerase activity are mechanistically linked to the regenerative capacity of the heart.
• Cardiac fibrosis after myocardial infarction is a major barrier to regeneration, and understanding the balance between repair and regeneration is central to the field.
• Biomaterials, extracellular vesicles, and bioactive particles are emerging tools to promote cardiac muscle tissue regeneration.
Description
GO:0061026 cardiac muscle tissue regeneration is defined as the regrowth of cardiac muscle tissue to repair injured or damaged muscle fibers in the postnatal stage. This process is distinct from developmental cardiogenesis because it occurs after birth and is directed toward restoring functional myocardium after injury. The capacity for cardiac muscle tissue regeneration varies dramatically across species and developmental stages: adult zebrafish can regenerate their hearts after resection, whereas the neonatal mouse heart can regenerate for only a brief window after birth before this capacity is lost. In humans, the adult heart is generally considered a post-mitotic organ with minimal regenerative capacity, making myocardial infarction a leading cause of irreversible heart failure. Understanding the molecular and cellular basis of cardiac muscle tissue regeneration is therefore a central goal of cardiovascular research, with the aim of reactivating endogenous repair programs or delivering exogenous regenerative factors. Recent work has explored diverse strategies, including the use of regenerating neonatal heart tissue-derived extracellular vesicles, tissue-inducing biomaterials, and bioactive glass and silica particles, to promote cardiac muscle tissue regeneration. This article synthesizes the current understanding of GO:0061026, its mechanisms, key genes, disease relevance, and the experimental methods used to study it.
cardiac muscle tissue regeneration At A Glance
| GO ID | GO:0061026 |
|---|---|
| GO term | cardiac muscle tissue regeneration |
| Ontology | biological_process |
| Synonym | None listed in QuickGO |
| Definition | The regrowth of cardiac muscle tissue to repair injured or damaged muscle fibers in the postnatal stage. |
| Major function | Restoration of cardiac muscle tissue after injury through regrowth of muscle fibers. |
| Related processes | Cardiac fibrosis, myocardial infarction repair, cardiomyocyte proliferation, telomere maintenance. |
| Model organisms | Zebrafish, neonatal mouse, and other vertebrates with cardiac regenerative capacity. |
What Is GO:0061026?
According to the Gene Ontology, GO:0061026 cardiac muscle tissue regeneration is the biological process of regrowth of cardiac muscle tissue to repair injured or damaged muscle fibers in the postnatal stage. It encompasses the cellular and molecular events that restore cardiac muscle tissue integrity and function after damage, rather than the initial formation of the heart during embryogenesis.
Why Is cardiac muscle tissue regeneration Important in Cell Biology?
Cardiac muscle tissue regeneration is critically important because the adult human heart has very limited capacity to replace lost cardiomyocytes after injury, and myocardial infarction leads to scar formation, adverse remodeling, and heart failure. Identifying the mechanisms that enable regeneration in neonatal mice and zebrafish could reveal therapeutic targets to restore cardiac function in humans. Research into GO:0061026 also informs the development of regenerative biomaterials and extracellular vesicle-based therapies, and highlights the role of telomere maintenance in sustaining regenerative potential.
• Myocardial infarction causes irreversible cardiomyocyte loss and fibrosis, making regeneration a major unmet clinical need.
• The neonatal mouse heart provides a tractable mammalian model of transient regenerative capacity.
• Zebrafish heart regeneration offers a powerful genetic model for discovering conserved regenerative mechanisms.
• Telomere length and telomerase activity are associated with the heart's regenerative capacity.
• Cardiac regeneration research informs cell-free therapies such as extracellular vesicles from regenerating tissue.
• Tissue-inducing biomaterials are being designed to support cardiac tissue regeneration and repair.
• Bioactive glass and silica particles are explored as scaffolds or cues for skeletal and cardiac muscle regeneration.
• Understanding the balance between fibrosis and regeneration is key to preventing heart failure after injury.
• Comparative studies across species can identify barriers to regeneration in adult mammals.
• Advances in cardiac regeneration could reduce the need for heart transplantation.
What Happens During cardiac muscle tissue regeneration?
Injury sensing and early response
In simple terms: When the heart is damaged, the tissue first detects the injury and triggers an emergency response.
After myocardial infarction, cardiomyocyte death and tissue damage initiate an inflammatory and reparative response that can lead to fibrosis and scar formation. In regenerating models such as the neonatal mouse, this early response is followed by a regenerative program rather than permanent scarring. The initial injury signals are thought to set the stage for either repair or regeneration.
Cardiomyocyte proliferation and tissue regrowth
In simple terms: Existing heart muscle cells divide to replace the ones that were lost.
In the neonatal mouse, regeneration after apical resection or myocardial infarction occurs through proliferation of pre-existing cardiomyocytes. In zebrafish, heart regeneration after resection involves dedifferentiation and proliferation of cardiomyocytes to rebuild the lost myocardium. This proliferative phase is a hallmark of cardiac muscle tissue regeneration and is absent or limited in the adult mammalian heart.
Resolution of fibrosis and remodeling
In simple terms: The scar tissue is minimized or removed so that muscle can be restored.
Cardiac fibrosis is a major impediment to regeneration, and the balance between fibrotic repair and regenerative regrowth determines functional outcome after infarction. In regenerating hearts, the fibrotic response is transient and is resolved as muscle tissue is restored. Understanding how fibrosis is limited in regenerative contexts is a key goal for promoting cardiac muscle tissue regeneration in adults.
Telomere maintenance and regenerative capacity
In simple terms: The protective ends of chromosomes help determine how long the heart can keep regenerating.
Telomeres and telomerase activity have been implicated in the regulation of heart regeneration, with telomere shortening associated with loss of regenerative capacity. Maintaining telomere integrity may support the proliferative capacity required for cardiac muscle tissue regeneration. This links cellular aging mechanisms to the regenerative potential of the heart.
Extracellular cues and biomaterial support
In simple terms: Signals from outside the cells, and engineered materials, can help the heart rebuild itself.
Extracellular vesicles derived from regenerating neonatal heart tissue have been shown to promote cardiac repair. Tissue-inducing biomaterials are designed to provide physical and biochemical cues that support cardiac tissue regeneration and repair. Bioactive glass and silica particles have also been investigated for their ability to support skeletal and cardiac muscle tissue regeneration.
Key Genes Involved in GO:0061026 cardiac muscle tissue regeneration
The following genes and proteins have been implicated in cardiac muscle tissue regeneration or in the regenerative response of the heart.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TERT | Telomerase catalytic subunit; maintains telomere length | Linked to regenerative capacity of the heart |
| MYH7 | Cardiac muscle myosin heavy chain | Marker of cardiomyocyte identity in regeneration studies |
| ACTC1 | Cardiac actin | Structural component of cardiac muscle; relevant to tissue regrowth |
| TNNT2 | Cardiac troponin T | Cardiomyocyte marker used to assess regeneration |
| NPPA | Atrial natriuretic peptide | Marker of cardiomyocyte stress and dedifferentiation in regeneration |
| NPPB | Brain natriuretic peptide | Marker of cardiac stress and remodeling |
| GATA4 | Cardiac transcription factor | Regulates cardiomyocyte gene expression and proliferation |
| MEF2C | Cardiac transcription factor | Controls cardiomyocyte differentiation and structural genes |
| HAND2 | Cardiac transcription factor | Involved in cardiac development and regeneration |
| TBX5 | Cardiac transcription factor | Essential for heart development and cardiomyocyte function |
| NKX2-5 | Cardiac transcription factor | Master regulator of cardiac gene programs |
| VEGFA | Vascular endothelial growth factor A | Promotes angiogenesis supporting regenerating tissue |
| IGF1 | Insulin-like growth factor 1 | Supports cardiomyocyte survival and proliferation |
| FGF1 | Fibroblast growth factor 1 | Implicated in cardiac repair and regeneration |
| PDGFB | Platelet-derived growth factor B | Regulates fibrosis and repair after injury |
| CTGF | Connective tissue growth factor | Promotes fibrosis, opposing regeneration |
| COL1A1 | Type I collagen | Major component of fibrotic scar after infarction |
How Is cardiac muscle tissue regeneration Regulated?
Cardiac muscle tissue regeneration is regulated by a complex interplay of developmental signaling pathways, telomere maintenance, and the balance between fibrotic and regenerative responses. Telomerase activity and telomere length influence the proliferative capacity of cardiomyocytes and are associated with the heart's regenerative potential. After myocardial infarction, the repair response is dominated by fibrosis and remodeling, which can suppress regeneration. In neonatal mice, the regenerative window is transient and is lost within the first week of life, suggesting developmental regulation of regenerative capacity. In zebrafish, regeneration is regulated by conserved signaling pathways that control cardiomyocyte dedifferentiation and proliferation. Extracellular vesicles and biomaterials can modulate these regulatory networks to promote cardiac repair.
cardiac muscle tissue regeneration and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TERT | Age-related loss of cardiac regeneration | Telomerase knockout or overexpression in neonatal mouse heart |
| COL1A1 | Cardiac fibrosis after myocardial infarction | Fibrosis induction in mouse models of infarction |
| CTGF | Fibrotic remodeling and scar formation | Knockout or knockdown in cardiac injury models |
| VEGFA | Impaired angiogenesis after infarction | Overexpression in ischemic heart models |
| IGF1 | Cardiomyocyte survival and repair | Overexpression in cardiac injury models |
Myocardial infarction and heart failure
Myocardial infarction causes cardiomyocyte death and triggers a reparative response that leads to fibrosis and scar formation, ultimately contributing to heart failure. The limited regenerative capacity of the adult human heart means that lost muscle is not replaced, making cardiac muscle tissue regeneration a major therapeutic target. Strategies to enhance endogenous regeneration or deliver regenerative factors are being actively investigated.
Cardiac fibrosis
Cardiac fibrosis is a pathological process that replaces damaged muscle with scar tissue and is a major barrier to cardiac muscle tissue regeneration. Fibrotic remodeling after infarction involves activation of fibroblasts and deposition of extracellular matrix proteins such as collagen. Understanding how to limit fibrosis while promoting muscle regrowth is central to improving outcomes after cardiac injury.
Age-related loss of regenerative capacity
The regenerative capacity of the heart declines with age, and telomere shortening has been implicated in this loss. Neonatal mice can regenerate their hearts, but this ability is lost shortly after birth. Age-related changes in telomere maintenance and cellular senescence may limit the effectiveness of regenerative therapies.
From cardiac muscle tissue regeneration-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate gene promote cardiomyocyte proliferation? | Knockout or overexpression in neonatal mouse heart |
| Is a gene required for zebrafish heart regeneration? | Knockout or knockdown in zebrafish resection model |
| Does a mutation affect telomere maintenance in regeneration? | Point mutation in TERT in mouse models |
| Can a secreted factor enhance cardiac repair? | Knock-in or overexpression of the factor in injury models |
| Do extracellular vesicles from regenerating tissue promote repair? | Injection of vesicles in myocardial infarction models |
| Do biomaterials support cardiac tissue regeneration? | Implantation of biomaterials in cardiac injury models |
How to Study the cardiac muscle tissue regeneration Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lineage tracing | Origin of new cardiomyocytes | Neonatal mouse heart regeneration |
| EdU/BrdU incorporation | Cell proliferation | Zebrafish and mouse heart regeneration |
| RNA-seq | Global gene expression changes | Comparative regeneration studies |
| Single-cell RNA-seq | Cell-type-specific transcriptional programs | Identifying regenerative cell states |
| Immunofluorescence | Protein localization and tissue structure | Assessing regeneration and fibrosis |
| Histology | Tissue morphology and scar size | Post-infarction remodeling |
| Extracellular vesicle assays | Functional effects of vesicles on cardiac cells | Cardiac repair studies |
| Biomaterial implantation | Tissue integration and regeneration | Cardiac tissue engineering |
Lineage tracing and proliferation assays
Lineage tracing using genetic labels allows researchers to determine whether new cardiomyocytes arise from pre-existing cardiomyocytes during cardiac muscle tissue regeneration. Proliferation markers such as EdU or BrdU incorporation are used to quantify cardiomyocyte division in neonatal mouse and zebrafish models. These methods are essential for distinguishing true regeneration from scar formation.
Transcriptomics and single-cell RNA sequencing
RNA sequencing and single-cell transcriptomics can identify gene expression programs associated with cardiac muscle tissue regeneration. Comparative analyses between regenerative and non-regenerative stages or species can reveal conserved and divergent pathways. These approaches help prioritize candidate genes for functional studies.
Imaging and histology
Histological staining and immunofluorescence for cardiac markers such as TNNT2 and ACTC1 are used to assess tissue regeneration and scar size. Advanced imaging techniques can track functional recovery after injury in animal models. These methods provide spatial and structural context for molecular findings.
Biomaterial and extracellular vesicle assays
Biomaterials and extracellular vesicles are tested for their ability to promote cardiac muscle tissue regeneration in vitro and in vivo. Functional assays include cardiomyocyte survival, proliferation, and contractility measurements. These translational approaches aim to develop new therapies for cardiac repair.
How CRISPR Can Be Used to Study GO:0061026 cardiac muscle tissue regeneration
Knockout
CRISPR knockout can be used to test whether a candidate gene is required for cardiac muscle tissue regeneration. For example, knocking out TERT in mouse models can reveal its role in telomere maintenance and regenerative capacity. Knockout of fibrotic genes such as COL1A1 or CTGF may reduce scar formation and enhance regeneration. In zebrafish, knockout of genes implicated in cardiomyocyte proliferation can be tested in the resection model.
Point Mutation
Point mutations can be introduced to model specific amino acid changes that affect protein function in cardiac regeneration. For example, mutations in TERT that alter telomerase activity can be used to study the relationship between telomere maintenance and regeneration. Point mutations in cardiac transcription factors such as GATA4 or NKX2-5 can reveal their functional domains in regeneration.
Knock-in
Knock-in of reporter genes or tags allows visualization and tracking of specific cell types or proteins during cardiac muscle tissue regeneration. For example, knock-in of fluorescent reporters into cardiomyocyte-specific loci enables lineage tracing. Knock-in of human disease-associated mutations can model their effects on cardiac repair.
Overexpression
Overexpression of pro-regenerative factors such as IGF1 or VEGFA can be achieved via CRISPR-mediated knock-in of a strong promoter or by transgenic approaches. Overexpression of extracellular vesicle-associated proteins may enhance their regenerative effects. These models help determine whether a factor is sufficient to promote cardiac muscle tissue regeneration.
How EDITGENE Supports cardiac muscle tissue regeneration Research
Researchers studying cardiac muscle tissue regeneration-related genes often need to determine whether a candidate gene is causally involved in the regenerative response. EDITGENE provides CRISPR-based cell models and screening services to accelerate this discovery process.
Contact EDITGENE today to design your custom CRISPR model for cardiac muscle tissue regeneration research.
Frequently Asked Questions About cardiac muscle tissue regeneration
What is GO:0061026 cardiac muscle tissue regeneration?
GO:0061026 is the biological process of regrowth of cardiac muscle tissue to repair injured or damaged muscle fibers in the postnatal stage.
What genes are involved in cardiac muscle tissue regeneration?
Genes such as TERT, GATA4, NKX2-5, and VEGFA have been implicated in cardiac regeneration and repair.
Can the adult human heart regenerate?
The adult human heart has very limited regenerative capacity, and myocardial infarction typically leads to scar formation rather than muscle replacement.
Which animals can regenerate their hearts?
Zebrafish can regenerate their hearts throughout life, and neonatal mice have a transient regenerative capacity that is lost shortly after birth.
What is the role of telomeres in heart regeneration?
Telomere maintenance and telomerase activity are associated with the regenerative capacity of the heart.
How is cardiac fibrosis related to regeneration?
Cardiac fibrosis replaces damaged muscle with scar tissue and is a major barrier to cardiac muscle tissue regeneration.
What are the research methods to study cardiac muscle tissue regeneration?
Methods include lineage tracing, proliferation assays, RNA-seq, single-cell RNA-seq, imaging, and biomaterial-based assays.
Can extracellular vesicles promote cardiac repair?
Extracellular vesicles derived from regenerating neonatal heart tissue have been shown to promote cardiac repair.
What is the role of biomaterials in cardiac regeneration?
Tissue-inducing biomaterials are designed to support cardiac tissue regeneration and repair, and bioactive glass and silica particles have been explored for muscle tissue regeneration.
How can CRISPR be used to study cardiac muscle tissue regeneration?
CRISPR can create knockout, point mutation, knock-in, and overexpression models to test the causal role of candidate genes in cardiac regeneration.
Conclusion
GO:0061026 cardiac muscle tissue regeneration is a fundamental biological process with direct relevance to human cardiovascular disease. While the adult mammalian heart has limited regenerative capacity, studies in zebrafish and neonatal mice have revealed conserved mechanisms that could be harnessed therapeutically. Key regulators include telomere maintenance pathways, developmental transcription factors, and extracellular cues from vesicles and biomaterials. Continued research using CRISPR-based models and advanced omics will be essential to translate these findings into clinical strategies for heart repair.
References
- 1. Ege D et al.. 2024. Bioactive Glass and Silica Particles for Skeletal and Cardiac Muscle Tissue Regeneration.. Tissue Eng Part B Rev 30(4):448-461 PMID: 38126329
- 2. Talman V et al.. 2016. Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration.. Cell Tissue Res 365(3):563-81 PMID: 27324127
- 3. Porrello ER et al.. 2011. Transient regenerative potential of the neonatal mouse heart.. Science 331(6020):1078-80 PMID: 21350179
- 4. Poss KD et al.. 2002. Heart regeneration in zebrafish.. Science 298(5601):2188-90 PMID: 12481136
- 5. Aix E et al.. 2018. Telomeres and telomerase in heart regeneration.. Differentiation 100:26-30 PMID: 29453108
- 6. Anversa P et al.. 2006. Cardiac regeneration.. J Am Coll Cardiol 47(9):1769-76 PMID: 16682300
- 7. Li H et al.. 2025. Cardiac repair using regenerating neonatal heart tissue-derived extracellular vesicles.. Nat Commun 16(1):1292 PMID: 39900896
- 8. Shafiq M et al.. 2026. Tissue-Inducing Biomaterials for Cardiac Tissue Regeneration and Repair.. Tissue Eng Part A 32(7-8):273-287 PMID: 41468067
